A controlled trial of recombinant methionyl human BDNF in ALS

Neurology

Volumn 52, Issue 7, 1999, Pages 1427-1433

  Bradley, Walter G ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; PLACEBO; RILUZOLE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INTESTINE FUNCTION; INTRATHECAL DRUG ADMINISTRATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NERVE GROWTH; NERVE INJURY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL;

EID: 0344076149     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.7.1427     Document Type: Article

References (23)

1. Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Lancet 1996;347:1425-1431.
2. Munsat TL, Bradley WG. Amyotrophic lateral sclerosis. In: Tyler HR, Dawson DM. Current neurology. Vol 2. Boston: Houghton Mifflin, 1979:9-103.
3. Kurtzke JF. Epidemiology of amyotrophic lateral sclerosis human. In: Rowland LP. Human motor neuron diseases. New York: Raven Press, 1982:281-302.
4. Norris F, Shepherd R, Denys E, et al. Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci 1993;118:48-55.
5. Lindsay RM. Brain-derived neurotrophic factor: an NGF-related neurotrophin. In: Fallon JH, Loughlin SE. Neurotrophic factors. New York: Academic Press, 1993:257-284.
6. Henderson CE, Camu W, Mettling C, et al. Neurotrophins promote motor neuron survival and are present in embryonic limb bud. Nature 1993;363:266-270.
7. Yan Q, Elliott J, Snider WD. Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death. Nature 1992;360:753-755.
8. Sendtner M, Holtmann B, Kolbeck R, Thoenen H, Barde YA. Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature 1992; 360:757-759.
9. Novikov L, Novikova L, Kellerth JO. Brain-derived neurotrophic factor promotes survival and blocks nitric oxide synthase expression in adult rat spinal motoneurons after ventral root avulsion. Neurosci Lett 1995;200:45-48.
10. Meyer M, Matsuoka I, Wetmore C, Olson L, Thoenen H. Enhanced synthesis of brain-derived neurotrophic factor in the lesioned peripheral nerve: different mechanisms are responsible for regulation of BDNF and NGF mRNA. J Cell Biol 1992; 119:45-54.
11. Koliatsos VE, Clatterbuck RE, Winslow JW, Cayouette MH, Price DL. Evidence that brain-derived neurotrophic factor is a trophic factor for motor neurons in vivo. Neuron 1993;10:359-367.
12. Piehl F, Frisen J, Risling M, Hoekfelt T, Cullheim S. Increased trkB mRNA expression by axotomized motoneurones. Neuroreport 1994;5:697-700.
13. Mitsumoto H, Ikeda K, Klinkosz B, Cedarbaum JM, Wong V, Lindsay RM. Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF. Science 1994;265:1107-1110.
14. Ikeda K, Klinkosz B, Greene T, et al. Effects of brain-derived neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease. Ann Neurol 1995;37:505-511.
15. Bradley WG. A phase I/II study of recombinant brain-derived neurotrophic in patients with ALS. Ann Neurol 1995;38:971. Abstract.
16. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases, El Escorial "Clinical Limits of Amyotrophic Lateral Sclerosis" Workshop Contributors. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994; 124(suppl):96-107.
17. ACTS Phase III Study Group. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol 1996;53:141-147.
18. Zar JR. Biostatistical analysis. 2nd ed. New Jersey: Prentice-Hall, 1984.
19. Rubin D. Multiple imputation for nonresponse in surveys. New York: Wiley, 1987.
20. Lavori PW, Dawson R, Shera D. A multiple imputation strategy for clinical trials with truncation of patient data. Stat Med 1995;14:1913-1925.
21. SAS Institute, Inc. SAS language: reference. Version 6. 1st ed. Cary, NC: SAS Institute, 1990.
22. Stambler N, Charatan M, Cedarbaum JM, et al. Prognostic indicators of survival in ALS. Neurology 1998;50:66-72.
23. Ochs G, Penn RD, Giess R, Schrank B, Sendtner M, Toyka KV. A trial of recombinant methionyl human brain-derived neurotrophic factor (BDNF) given by intrathecal (IT) infusion to patients with amyotrophic lateral sclerosis (ALS). Neurology 1998;50(suppl):A246. Abstract.